Transcript
COMPANY REVIEW SESSION
PRESENTED BY-MONIKA LOHIA (D-54)
GROWING TOGETHER • Sun Pharmaceutical Industries Limited (
NSE: SUNPHARMA, BSE: 524715) is • An Indian multinational pharmaceutical
company headquartered in Mumbai. • Manufactures and sells pharmaceutical
formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.
OVERVIEW• Started as partnership firm by Mr. Dilip Shanghavi in
1983 in Vapi with just five products to treat psychiatry ailments.
• Cardiology products were introduced in 1987 followed by gastroenterology products in 1989.
• Today it is the largest chronic prescription company in India and a market leader in psychiatry, neurology, cardiology, orthopaedics, ophthalmology, gastroenterology and nephrology.
• The 2015 acquisition of Ranbaxy has made the company the largest pharma company in India
KEY PEOPLE
CREATING VALUE
LEADERSHIP IN KEY THERAPEUTIC AREAS
KEY ACQUISITIONS
KEY PERFORMANCE INDICATORS
SPENDING DISTRIBUTION (GEOGRAPHY WISE)
GLOBAL MANUFACTURING FOOTPRINTS
SHARE HOLDINGS
STOCK MARKET
BALANCE SHEET
PROFIT AND LOSS STATEMENT
FINANCIAL RATIOS
RECENT NEWS• March 8, 2016- Sun Pharma signs M S Dhoni
as Revital H brand ambassador• Feb 12, 2016- Sun Pharma Q3 net profit
surges over 3-fold to Rs 1,417 crore• Jan 29, 2016- Sun Pharmaceuticals to sell
some low priority Ranbaxy brands • Dec 19, 2015- U.S. FDA warns Sun Pharma
over standards at Halol plant (Gujrat)• Sep 1 2015- Sun Pharma completes
acquisition of GSK Australia opiates biz
CONCLUSIONSun pharmaceuticals is performing well financials show that the company has huge scope of growth.After acquiring Ranbaxy it has become 5th largest pharmaceutical company in the world.So it is recommended to invest in this company.
ANY QUESTIONS ?
top related